Mantle Cell Lymphoma (MCL) Active Not Recruiting Phase 2 Trials for Cytarabine (DB00987)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00878254Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell LymphomaTreatment
NCT01661881Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell LymphomaTreatment
NCT02427620Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell LymphomaTreatment
NCT02896582Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven MaintenanceTreatment
NCT02633137Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell LymphomaTreatment
NCT00992446Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin LymphomaTreatment